Cannabis use and social anxiety in young adulthood: A meta-analysis.

Cannabis problems Cannabis use frequency Meta-analysis Social anxiety Young adulthood

Journal

Addictive behaviors
ISSN: 1873-6327
Titre abrégé: Addict Behav
Pays: England
ID NLM: 7603486

Informations de publication

Date de publication:
06 2022
Historique:
received: 02 09 2021
revised: 31 01 2022
accepted: 01 02 2022
pubmed: 21 2 2022
medline: 22 3 2022
entrez: 20 2 2022
Statut: ppublish

Résumé

Young adulthood (ages 18 to 30 years old), a developmental age of exploration, is marked by new experiences and transitions. Cannabis use frequency is highest in young adulthood compared to other age periods. Social anxiety (characterized by fear, shyness, and inhibition in social situations where scrutiny and judgment is possible) is also prevalent during young adulthood. Social anxiety may be a complex predictor of cannabis use frequency and problems (e.g., any negative physical, emotional, or social outcome from use). Social anxiety may act as a risk factor as individuals may use cannabis frequently to manage their fear of negative evaluation and associated unpleasant affective states. The purpose of this meta-analysis was to quantify the magnitude of the associations between social anxiety and two cannabis variables (frequency of use and problems) in young adulthood. A comprehensive literature review was conducted to identify studies that included measures of social anxiety and at least one cannabis-related variable of interest among young adults. Eighteen studies were included in the meta-analysis. Results revealed a small, statistically significant positive association between social anxiety and cannabis problems (r = 0.197, k = 16, p = <0.001), and a nonsignificant association between social anxiety and cannabis use frequency (r = 0.002, k = 16, p = 0.929). The association between social anxiety and cannabis use frequency was moderated by the mean age such that samples with older mean ages exhibited a stronger correlation. Additionally, the association between social anxiety and cannabis problems was moderated by clinically significant levels of social anxiety, such that samples with fewer participants who met clinical levels of social anxiety exhibit a stronger correlation. This meta-analysis supports the idea that there is a complex relation between social anxiety and cannabis outcomes during young adulthood.

Identifiants

pubmed: 35184002
pii: S0306-4603(22)00041-7
doi: 10.1016/j.addbeh.2022.107275
pii:
doi:

Types de publication

Journal Article Meta-Analysis Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

107275

Informations de copyright

Copyright © 2022 Elsevier Ltd. All rights reserved.

Auteurs

Alanna Single (A)

Department of Psychology, University of Manitoba, 190 Dysart Road, Winnipeg, Manitoba R3T 2N2, Canada. Electronic address: singlea@myumanitoba.ca.

Elena Bilevicius (E)

Department of Psychology, University of Manitoba, 190 Dysart Road, Winnipeg, Manitoba R3T 2N2, Canada. Electronic address: bilevice@myumanitoba.ca.

Victoria Ho (V)

University of Manitoba Libraries, University of Manitoba, 25 Chancellors Circle, Winnipeg, Manitoba R3T 5V5, Canada. Electronic address: victoria.ho@umanitoba.ca.

Jennifer Theule (J)

Department of Psychology, University of Manitoba, 190 Dysart Road, Winnipeg, Manitoba R3T 2N2, Canada. Electronic address: jen.theule@umanitoba.ca.

Julia D Buckner (JD)

Department of Psychology, Louisiana State University, 236 Audubon Hall, Baton Rouge Louisiana 70803, United States. Electronic address: jbuckner@lsu.edu.

Natalie Mota (N)

Department of Clinical Health Psychology, University of Manitoba, 771 Bannatyne Avenue, Winnipeg, Manitoba R3E 3N4, Canada. Electronic address: natalie.mota@umanitoba.ca.

Matthew T Keough (MT)

Department of Psychology, York University, 4700 Keele St, North York, Ontario M3J 1P3, Canada. Electronic address: keoughmt@yorku.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH